510(k) device
GammaPod
Xcision Medical Systems, LLC · System, Radiation Therapy, Radionuclide (IWB, Class II) · First FDA decision Dec 22, 2017, newest Apr 4, 2018Brain tumorsCancer radiation therapy
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
2
Naming "GammaPod"
MAUDE reports
0
Brand "GammaPod", since 2015
PubMed studies
24
Mentioning "GammaPod"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing GammaPod
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- GammaPod510(k)
K180571 · Decided Apr 4, 2018 · 30 days after receipt
Device type: System, Radiation Therapy, Radionuclide (IWB) · Radiology & Imaging
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Hyperbaric Oxygen Therapy for Chronic Radiation Induced Proctitis and EnteritisNational analysisReview closedCAG-00060R2Updated Nov 18, 2026
- Stereotactic Radiation Therapy: Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT)Local determinationIn effectL35076Wellpoint FederalUpdated Jul 14, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40168Wellpoint FederalUpdated Jul 14, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40179CGS Administrators, LLCUpdated Apr 17, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40193WPS Insurance CorporationUpdated Mar 12, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40189Palmetto GBAUpdated Mar 11, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40176Noridian Healthcare Solutions, LLCUpdated Mar 10, 2026
- Intraoperative Radiation TherapyLocal determinationIn effectL37779Palmetto GBAUpdated Jul 23, 2021
Clinical trials
Device studies on ClinicalTrials.gov that name "GammaPod", any status and sponsor, newest update first.
- Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using GammapodActive, not recruiting
University of Texas Southwestern Medical CenterAcademic, hospital or other
NCT03581136 · 74 participants · Start Apr 22, 2019 · Primary completion May 25, 2028
Device: Dose Fractionation · For: Breast Cancer
Sites: Baltimore, Maryland; Dallas, Texas
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "GammaPod", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code IWB
27 reports: 20 malfunction, 6 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0750-2024 · Started Nov 30, 2023 · Posted by FDA Jan 18, 2024
Reason given: Wrong structures imported into the GammaPod Treatment Planning System.-system allowed an RTSS generated from a previous CT scan to be selected
Cause as FDA categorized it: Software design · Device type: System, Radiation Therapy, Radionuclide (IWB)
1 more recall records with a free account
Published research
The most relevant PubMed records for "GammaPod"[tiab]. The summary above synthesizes these.
- Global optimization for spot-based treatment planning.
Chen M, Gu X, Lu W · Med Phys · 2022
- Commissioning and acceptance guide for the GammaPod.
Becker S, Sabouri P, Niu Y, et al. · Phys Med Biol · 2019
- Correlation of treatment time to target volume for GammaPod treatments: A simple second calculation.
Chen L, Becker SJ, McAvoy SA, et al. · J Appl Clin Med Phys · 2022
- GammaPod-a new device dedicated for stereotactic radiotherapy of breast cancer.
Yu CX, Shao X, Zhang J, et al. · Med Phys · 2013Research Support, N.I.H., Extramural
- Technical Note: Dosimetric feasibility of lattice radiotherapy for breast cancer using GammaPod.
Kopchick B, Xu H, Niu Y, et al. · Med Phys · 2020
- A How-To Compendium for GammaPod Treatments, Clinical Workflow, and Clinical Program at an Early Adopting Institution.
Zhang-Velten E, Zhang Y, Radpour S, et al. · Pract Radiat Oncol · 2022
- Dosimetry evaluation of the GammaPod stereotactic radiosurgery device based on established AAPM and IAEA protocols.
Becker SJ, Culberson WS, Poirier Y, et al. · Med Phys · 2020
- Development and validation of a comprehensive patient-specific quality assurance program for a novel stereotactic radiation delivery system for breast lesions.
Becker SJ, Niu Y, Mutaf Y, et al. · J Appl Clin Med Phys · 2019Validation Study
- Verifying calculated dose to the breast in stereotactic radiotherapy: A practical phantom-based method.
Becker SJ, Smith RE, Culberson WS, et al. · J Appl Clin Med Phys · 2026
- A Prospective Trial of Single-Fraction Radiation to the Tumor Bed with a Novel Breast-Specific Stereotactic Radiation Therapy Device: The GammaPod.
Nichols EM, Bentzen SM, Milburn M, et al. · Adv Radiat Oncol · 2024
- POD-DOSI: A dedicated dosimetry system for GammaPod commissioning and quality assurance.
Parsons D, Zhang Y, Gu X, et al. · Med Phys · 2020
- A deep learning approach for automatic delineation of clinical target volume in stereotactic partial breast irradiation (S-PBI).
Kazemimoghadam M, Yang Z, Chen M, et al. · Phys Med Biol · 2023Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code IWB.
- Leksell Gamma Knife Perfexion, Leksell Gamma Knife IconElekta Instrument AB · 510(k) 2018
- Leksell Gamma Knife® (Elekta Esprit)Elekta Solutions AB · 510(k) 2025
- Leksell GammaPlanElekta Instrument AB · 510(k) 2018
- Leksell GammaPlan (LGP)Elekta Solutions AB · 510(k) 2024
- TaiChiCOur United Corporation · 510(k) 2021
- Akesis Galaxy RTiAkesis, Inc. · 510(k) 2021
- Akesis Galaxy RTxAkesis, Inc. · 510(k) 2020
- Akesis GalaxyAkesis, Inc. · 510(k) 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.